atlizumab humanized monoclonal antibody drug also known tocilizumab targets the interleukin receptor and used |
||||||||||||||||||||||||||||||||||||||||
| navigate by keyword : antibody arthritis atlizumab biological biosimilar biotech biotechnology castleman disease drug il6r immunoglobulin immunology immunosuppressive infusion injection inn interleukin mab monoclonal nomenclature peptide protein rheumatoid tocilizumab |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Atlizumab humanized monoclonal antibody drug. Also known as tocilizumab. Targets the interleukin-6 receptor (IL-6R) and is used in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis. Generic name and stylized antibody representation |
||||||||||||||||||||||||||||||||||||||||
|
Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners. |
||||||||||||||||||||||||||||||||||||||||
